3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
26
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Sarcoma
9
Lung Neoplasms
6
Uterine Cervical Neoplasms
5
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neoplasms
3
Liposarcoma, Myxoid
3
Head and Neck Neoplasms
3
Glioblastoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Carcinoma In Situ
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Radiation Injuries
2
Neurofibrosarcoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphatic Metastasis
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Cholangiocarcinoma
2
Interventions
Fluorouracil
218
Leucovorin
201
Oxaliplatin
191
Irinotecan
148
Bevacizumab
107
Capecitabine
93
Cetuximab
89
Folfox protocol
54
Chemotherapy, Adjuvant
34
Panitumumab
30
pembrolizumab
23
Nivolumab
22
Colonoscopy
22
Gemcitabine
20
Magnetic Resonance Spectroscopy
19
Floxuridine
19
IFL protocol
18
Celecoxib
18
Radiotherapy
17
Neoadjuvant Therapy
17
Early Intervention, Educational
17
Drug Therapy
17
Laparoscopy
14
Cyclophosphamide
14
Counseling
14
trifluridine tipiracil drug combination
13
regorafenib
13
XELOX
13
Exercise
13
Erlotinib Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
NCT01936961
2017-06-27
I-CREST
Western Regional Medical Center
Phase NA
Withdrawn